1-3 of 3
Toni Weinschenk, PhD
Close
Sort by
Journal Articles

Effective Targeting of PRAME-Positive Tumors with Bispecific T Cell-Engaging Receptor (TCER ® ) Molecules

Sebastian Bunk, PhD, Martin Hofmann, PhD, Felix Unverdorben, PhD, Meike Hutt, PhD, Gabriele Pszolla, PhD, Frank Schwöbel, PhD, Claudia Wagner, PhD, Sara Yousef, PhD, Heiko Schuster, PhD, Sarah Missel, PhD, Oliver Schoor, PhD, Toni Weinschenk, PhD, Harpreet Singh-Jasuja, PhD, Dominik Maurer, PhD, Carsten Reinhardt, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3368.
https://doi.org/10.1182/blood-2019-129958
Published: 2019
Journal Articles

Identification and Characterization of T Cell Epitopes Deduced from RGS5, a Novel Broadly Expressed Tumor Antigen.

Cristina N. Boß, Frank Grünebach, PhD, Katharina M. Brauer, Toni Weinschenk, PhD, Lothar Kanz, MD, Stefan Stevanovic, PhD, Hans-Georg Rammensee, PhD, Peter Brossart, MD
Journal: Blood
Blood (2006) 108 (11): 3703.
https://doi.org/10.1182/blood.V108.11.3703.3703
Published: 2006
Journal Articles

The Effects of Imatinib on the Function of Monocyte Derived Dendritic Cells Are Mediated Via the Inhibition of Akt and NF-kappaB Signal Transduction Pathways.

Anette Rupf, MB, Silke Appel, PhD, Markus M. Weck, MS, Frank Grünebach, PhD, Lothar Kanz, MD, Oliver Schoor, MS, Tim H. Brümmendorf, MD, Toni Weinschenk, PhD, Peter Brossart, MD
Journal: Blood
Blood (2004) 104 (11): 3453.
https://doi.org/10.1182/blood.V104.11.3453.3453
Published: 2004